Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1242 participants.
Also called NCT02000115
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,242 participants
- Sponsor
- Registry
-
NCT02000115
-
- Other papers using this trial's data
- Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Australia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02000115. Randomized; no masking; primary purpose treatment. Start 2014-05 (actual); primary completion 2019-10 (actual). Results posted on 2021-01-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
- Acronym
- PORTICO-IDE
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- Portico transcatheter aortic valve
- Intervention (Device)
- Commercially available transcatheter aortic valve
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02000115- Content hash
7ea19c9a08b22a9d9cefa244e424972dc20394036e5e55ede4d3b482d5c85a1b